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ABSTRACT 
Į-Synuclein (AS) is an intrinsically 
disordered protein highly expressed in 
dopaminergic neurons. Its amyloid aggregates 
are the major component of Lewy bodies, a 
hallmark of Parkinson¶V disease (PD). AS is 
particularly exposed to oxidation of its 
methionine residues, both in vivo and in vitro. 
Oxidative stress has been implicated in PD and 
oxidized Į-synuclein has been shown to 
assemble into soluble, toxic oligomers, rather 
than amyloid fibrils. However, the structural 
effects of methionine oxidation are still poorly 
understood. In this work, oxidized AS  was 
obtained by prolonged incubations with 
dopamine (DA) or epigallocatechin-3-gallate 
(EGCG), two inhibitors of AS aggregation, 
indicating that EGCG promotes the same final 
oxidation product as DA. The conformational 
transitions of the oxidized and non-oxidized 
protein were monitored by complementary 
biophysical techniques, including MS, ion 
mobility (IM), CD and FTIR spectroscopy 
assays. Although the two variants displayed very 
similar structures under conditions that stabilize 
highly disordered or highly ordered states, 
differences emerged in the intermediate points of 
transitions induced by organic solvents, such as 
trifluoroethanol (TFE) and methanol (MeOH), 
indicating a lower propensity of the oxidized 
protein for forming either Į- or ȕ-type secondary 
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structure. Furthermore, oxidized AS displayed 
restricted secondary-structure transitions in 
response to dehydration and slightly amplified 
tertiary-structure transitions induced by ligand 
binding. This difference in susceptibility to 
induced folding could explain the loss of 
fibrillation potential observed for oxidized AS. 
 
D-Synuclein (AS) is a 140-residue, intrinsically 
disordered protein (IDP) (1) highly expressed in 
the presynaptic nerve terminals, where it plays a 
regulatory role in synaptic homeostasis (2±4). 
Three regions can be recognized in its primary 
structure: the N-terminal region, capable to bind 
membranes undergoing coil-to-helix transitions; 
the central, hydrophobic region involved in 
amyloid fibril formation; and the C-terminal, 
acidic region responsible for pH-dependent 
conformational transitions and binding to 
multiple protein interactors. AS aggregation is a 
hallmark of PD and related neurodegenerative 
disorders. Aggregated AS is the major 
component of Lewy bodies and AS mutations or 
altered expression correlate with increased risk 
of PD onset (4). 
AS oxidation has been long implicated 
in PD. However, the underlying molecular 
mechanisms are not clear yet. Due to the 
oxidative challenge represented by DA, 
dopaminergic neurons are particularly exposed 
to protein oxidative damage. AS can be oxidized 
on its four methionine residues (positions 1, 5, 
116, 127), in vivo and in vitro (5). Typical 
effective oxidants are DA, via its oxidation 
products, and H2O2 (6±9). Methionine-oxidized 
AS is inhibited in fibrillation and, rather, 
aggregates into soluble, SDS-resistant oligomers 
with variable degrees of cytotoxicity (9±12). 
Methionine sulfoxide epimers can be 
enzymatically reduced in vivo by the activity of 
methionine sulfoxide reductase (MSR) (13). In-
cell NMR, however, has shown that only Met1 
and Met5 are restored in oxidized AS, while the 
C-terminal positions 116 and 127 are not 
targeted by the cellular repair machinery in 
mammalian cells, which could lead to the 
accumulation of toxic species (14). 
Protein oxidation on methionine residues 
to give sulfoxide is thought to affect protein 
function mainly via structural effects (5). The 
modification causes, indeed, a remarkable loss 
of hydrophobic character of the methionine side 
chain, which could affect secondary and tertiary 
structure (7). Furthermore, methionine oxidation 
results in a lower intrinsic propensity for helical 
structures as shown on poly-Met polymers (15). 
In order to interpret the biological responses to 
AS oxidation, it is important to understand the 
effect of methionine oxidation per se on AS 
conformational transitions, dissecting it from 
other, frequently associated processes like 
protein-protein and protein-membranes 
interactions or other AS covalent modifications. 
Based on CD spectroscopy, fully 
oxidized (oMet4) AS appears to be slightly more 
disordered than non-oxidized (oMet0) AS, with 
minor losses of intrinsically formed helical 
segments (7). However, the spectra are almost 
superimposable and imprinted to a general 
character of highly disordered protein (7, 14, 
16). On the other hand, both proteins are highly 
helical in the presence of a strong molar excess 
of docosahexaenoic acid (DHA), with oMet4 AS 
displaying a similar helical content as oMet0 AS 
(17). Nevertheless, a conceivable hypothesis is 
that oxidation impacts on AS propensity to 
acquire ordered secondary/tertiary structure (7). 
Such a mechanism could be at the basis of 
different propensities of reduced and oxidized 
AS to populate the amyloidogenic conformer 
that triggers fibrillation. An indication of 
different conformational transitions of the two 
protein variants derives from NMR analysis of 
the helicity induced by N-terminal acetylation in 
the first 10 residues of the protein. The 
comparison of oMet4 and oMet0 AS indicates 
that oxidation inhibits the acetylation-induced 
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conformational transition in the N-terminal 
residues (18). 
This work focuses on the 
characterization of AS oxidation products, in 
order to test the hypothesis that methionine 
oxidation affects AS conformational transitions, 
in spite of the similar secondary structure 
displayed by oMet4 and oMet0 AS in highly 
disordered or highly helical states. Oxidation is 
monitored upon prolonged incubations with DA 
or EGCG. Both ligands inhibit AS fibrillation 
and induce formation of oligomers (10, 19), 
which are not toxic in the case of EGCG (19). 
The two ligands bind AS with distinct 
conformational selectivity, forming non-covalent 
and not-oxidized complexes upon short 
incubation time (20). However, it has been 
shown that AS can be oxidized by DA (9, 10), 
and other proteins by EGCG (21), after long 
incubation time. Here, AS oxidation is 
monitored by electrospray ionization mass 
spectrometry (ESI-MS) and the monomeric, 
soluble, fully oxidated product is analyzed by 
CD, FTIR spectroscopy and native MS, under 
conditions that promote either D- or E-type 
secondary structure. 
 
Results 
Oxidation kinetics 
AS susceptibility to covalent 
modifications in the presence of DA or EGCG 
has been investigated by incubating the protein 
with either ligand at 37 °C under mild agitation. 
2 mM DA and 200 µM EGCG were used as 
previously characterized conditions enabling 
effective detection of AS-ligand non-covalent 
complexes (20). Aliquots were taken at different 
time-points, purified from salts and free ligand, 
and analyzed by ESI-MS under denaturing 
conditions for intact protein detection. The data 
reported in Fig. 1A-C show that, under 
prolonged incubation, both ligands induce 
stepwise mass shifts of 16 Da in AS peaks, 
corresponding to progressive oxidation states. 
Up to 4 oxidations per AS molecule can be 
detected, which correspond to the number of 
methionine residues in the molecule. The species 
distributions evolve towards an almost 
homogeneous, 4-oxidized population after 72 h, 
with still ~10% of 3-oxidized protein detectable 
in the presence of DA and ~20% in the presence 
of EGCG (Fig. 1D,E). No covalent adducts with 
the ligands are detectable under these conditions. 
These results indicate that both ligands can 
induce AS oxidation. 
In order to map the modification sites 
and to describe their individual kinetics, 
chymotryptic peptides from the same samples as 
above were analyzed by ESI-MS (Fig. 2). Three 
oxidized methionine residues (positions 1, 116 
and 127, Table S1) were identified in samples 
incubated with either DA or EGCG by ESI-
MS/MS, indicating that the modification 
corresponds to sulfoxidation (Fig. S1). Likely, 
the fourth modification involves the peptide 
containing Met5, which could not be identified 
in either oxidized or non-oxidized form and is 
presumably lost during the purification 
procedure, due to its very small size. 
Quantification of the oxidation extent was 
obtained by the peak-height ratios between the 
oxidized and non-oxidized forms of each 
detected peptide (Fig. 2 A-C and S2). 
To retrieve direct evidence on the 
oxidation state of all four methionine residues, 
tryptic digests were analyzed, as well (Fig. 2). 
This procedure generates an N-terminal peptide 
containing Met1 and Met5 and a C-terminal 
peptide containing Met116 and Met127. The 
extent of oxidation at positions 1 and 5 could be 
assessed from the MS/MS data, as the ratio 
between peptide spectrum matches (PSMs) of 
the oxidized and non-oxidized form of the N-
terminal peptide (Fig. 2, S3, S4, S5 and Table 
S1). The use of MS/MS spectral counts method 
in place of the MS precursor-ion peak height 
made it possible to exactly calculate the 
contribution of single oxidation events on either 
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Met1 or Met5, thus enabling measurement of the 
oxidation rate of individual methionine residues 
(Fig. S5). This would not be possible using peak 
height or peak area calculations on the precursor 
ion, since the latter has the same m/z value 
whether the single oxidation concerns Met1 or 
Met5. The C-terminal tryptic peptide, instead, is 
too large to yield high-quality MS/MS spectra 
by collision-induced dissociation, hindering 
accurate sequence assignment and quantification 
of the oxidation levels. Thus, the extent of 
oxidation at positions 116 and 127 was better 
calculated from MS data of the respective 
chymotryptic peptides (Fig. 2A-C and Fig. S2). 
The list of the identified peptides by tryptic and 
chymotryptic digestions is reported in Table S1. 
The resulting, position-specific 
oxidation profiles are reported in Fig. 2D,E. It 
can be noticed that oxidation kinetics at 
positions 1, 5, and 116 are quite similar and 
reach a plateau around 40 h incubation under the 
here employed conditions, with either ligand. 
Oxidation of Met127, instead, is slightly but 
systematically delayed relative to the others. It is 
interesting to note that this residues belongs to 
the 125YEMPS129 motif, which has been 
implicated in long-range interactions with the 
central NAC (non-amyloid component) region 
and interaction with DA and its oxidation 
products (22±26). These local structural features 
are likely at the basis of the different oxidation 
kinetics of the Met127 residue. 
 
Secondary-structure transitions 
The conformational response of oMet0 
and oMet4 AS to organic solvents has been 
studied by far-UV CD. Under non-denaturing 
conditions the two species display typical 
spectra of intrinsically disordered proteins, 
characterized by a large amount of random coil 
(minimum at 200 nm), with a small D-helical 
component (shoulder at 222 nm) (7) (Fig. 3A). 
The addition of either TFE (Fig. 3B,C) or MeOH 
(Fig. 3E,F) induces, respectively, the acquisition 
of D- or E-type secondary structure by oMet0, as 
previously described (27). Under the same 
conditions, oMet4 AS displays a lower 
propensity to form ordered secondary structure 
relative to oMet0 AS, with higher concentrations 
of organic solvent being required to observe 
similar effects. Moreover, the final secondary 
structure displayed by the two proteins at high 
solvent concentrations (15% TFE and 40% 
MeOH), which correspond to the post-transition 
spectra of oMet0 AS (27), are not identical. In 
both cases, oMet4 AS shows a lower content of 
ordered secondary structure, particularly in the 
case of methanol-induced E-strands, as indicated 
by the lower intensity of the signal at 215 nm. 
AS incubation in the presence of DA is 
known to induce formation of soluble, SDS-
resistant oligomers. SDS-PAGE analysis 
indicates that higher-order species are 
detectable, particularly upon EGCG treatment. 
Their amount in the samples used here for CD 
titrations (Fig. 3D) is below 15%, as assessed 
from densitometry analysis (data not shown). 
The absence of bands in the pellet lanes of the 
gel rules out the presence of aggregates that 
become soluble in SDS and the comparable 
intensity of monomeric AS suggests that no 
significant amount of material is lost in the pellet 
of the final sample clarification after SDS 
solubilization. Some faint bands (~8%) can be 
detected at slightly lower molecular weight, 
likely due to some proteolytic degradation. In 
conclusion, the observed structural features can 
be ascribed to soluble, monomeric AS, which is 
the largely predominant species in the analyzed 
samples. Dynamic equilibrium with SDS-
sensitive oligomeric species cannot be ruled out, 
although it has not been described before, for AS 
under similar conditions. 
Secondary structure of oMet0 and oMet4 
AS has been analyzed also by FTIR 
spectroscopy. The absorption and second-
derivative spectra of AS samples, measured in 
the form of protein films, are reported in Fig. 
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4A,B for the Amide I band, which is mainly due 
to the stretching vibration of the peptide bond 
(28). The main spectral component around 1657 
cm-1 can be assigned to random coil with 
possible contribution of D-helical structures. 
Two additional peaks are evident around 1696 
cm-1 and 1627 cm-1. In agreement with a 
previous study, these peaks can be assigned to E-
sheet structures induced by solvent evaporation 
and protein-protein interactions in the film (29). 
The oMet4 protein displays a lower intensity of 
such component (Fig. 4A,B), indicating a lower 
content of ordered E-structures compared to 
oMet0 AS.  
The secondary structure of oMet0 and 
oMet4 AS has also been studied here by 
conventional FTIR measurements of the proteins 
in D2O solution (30, 31). The Amide I 
absorption and second-derivate spectra of the 
two proteins in solution at 30 °C are 
superimposable (Fig. 4C,D) and are 
characterized by a main component around 1642 
cm-1 assigned to random-coil structures (27±29, 
32). These data for the protein in solution are 
only in apparent contrast with those on protein 
films and can be interpreted by a role of 
dehydration in the observed response of semi-
dry oMet4. Thus, oxidation per se is not enough 
to induce major changes in AS secondary 
structure in solution but it reduces its propensity 
to form ordered structure, as those induced by 
dehydration.  
The conformational stability has been 
compared by applying temperature ramps. The 
spectral changes induced by heating the protein 
solutions from 25 °C to 100 °C are very similar 
for oMet0 and oMet4 AS (Fig. 4D-F). Therefore, 
FTIR analyses detect comparable secondary 
structure and temperature response for oMet0 
and oMet4 AS in D2O solution (Fig. 4C-F). It 
has been pointed out that such spectral changes 
of IDPs could also be interpreted as a loss of 
polyproline II-like structures, rather than 
acquisition of D-helices (33). 
In conclusion, conformational properties 
of oMet0 and oMet4 AS are very similar, as 
assessed by CD and FTIR. However, both 
techniques can capture differences under 
particular conditions, always in the direction of a 
reduced propensity of oMet4 to acquire ordered 
secondary structure. 
 
Ligand binding 
Native MS has been employed in order 
to evaluate the effects of oxidation on ligand 
binding by AS. Ternary mixtures of oMet0, 
oMet4 and either DA or EGCG have been 
analyzed by ESI-MS under non-denaturing 
conditions, allowing for comparison under 
identical conditions and direct protein 
competition for the same ligand. The spectra 
reveal complexes for each protein form, which 
can be distinguished by their distinct masses 
(Fig. 5). Ligand binding displays the same 
stoichiometry and the same conformational 
selectivity for the two protein variants, with 
preferential binding of DA to more extended 
conformations (charge states 10+ - 14+) and 
EGCG to more compact forms (charge states 6+ 
- 12+), as already reported  for the non-oxidized  
protein (20). The apparent affinities of DA for 
oMet0 and oMet4 seem to be comparable, too, 
since the amounts of complexes at each binding 
step are very similar (as seen for the 11+ and 8+ 
charge states in Fig. 5C and 5D). The latter has 
been chosen as the ion with the highest fraction 
of bound EGCG. The 11+ charge state for DA 
complexes has been selected as the lowest 
charge state with significant ligand bound, in 
order to prevent conformational artifacts induced 
by Coulomb repulsions which can contribute to 
higher charge states (20). These peaks are used 
for further analysis of the protein-ligand 
complexes. 
In order to obtain a more detailed 
description of structural compactness, the 
collision cross section (CCS) of the protein and 
its non-covalent complexes has been measured 
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by nano-ESI-ion mobility (IM) MS and shown 
in Fig. 6. The observed segregation of DA and 
EGCG complexes in the CSD reflects the 
previously reported (20) conformational 
selectivity of the two different ligands. Multiple 
conformers with slightly different compactness 
are distinguishable, even within the same charge 
state.  
For the 11+ charge state (Fig. 6A), the 
free protein populates almost exclusively the 
more compact conformer (b), irrespective of the 
oxidation state. As already shown previously 
(20), DA binding stabilizes the more extended 
conformer (a), giving larger collision cross-
sections (CCS). The more DA molecules bound, 
the higher the relative population of the a 
conformer. This effect is maintained in the 
oxidized protein variant, with minor differences. 
A small amplification of the effect can be 
observed in the oxidized form, with slightly 
larger fractions of the extended form detectable 
(Fig. 6). The effect, however, is barely 
significant (Table S2).  
The results for the 8+ charge state show 
at least five different conformers (c-g), 
consistent with an ensemble featuring also 
collapsed forms (Fig. 6B). Oxidation seems to 
affect species distributions whether or not 
EGCG is bound. Even in the free protein, the 
compact states below 2500 A2 CCS are slightly 
enriched in oMet4 relative to oMet0. As 
previously described (20), EGCG binding to AS 
promotes formation of these compact 
conformers (e-g). Oxidation amplifies such an 
effect, with slightly larger fractions of the 
collapsed species detectable at each 
stoichiometry (Fig. 6, Table S2). 
Thus, oxidation seems to play subtle 
effects in AS tertiary-structure transitions 
induced by ligands, with a slight amplification of 
the effects seen for the non-oxidized protein. 
The difference, however, is only in the relative 
amounts of the different conformers and not, 
apparently, in their structure. 
 
Discussion 
Several lines of evidence suggest that 
DA inhibition of AS fibrillation is mediated by 
methionine oxidation (8). In this work it is 
shown that EGCG, another ligand with 
inhibitory effects (19), induces methionine 
oxidation in AS, strengthening the hypothesis 
that accumulation of oMet4 AS plays a central 
role controlling the pathways of AS amyloid 
aggregation. The oxidative effects of DA and 
EGCG seem to be due to production of H2O2 in 
the presence of oxygen and further accumulation 
of the hydroxyl radical by the Fenton reaction in 
the presence of even traces of Cu+ or Fe2+ (5, 
34). In addition, distinct effects on AS 
conformation are induced by the formation of 
non-covalent complexes with DA and EGCG, 
with the stabilization of different protein 
conformers upon ligand binding (20). These 
ligand-specific effects could be responsible of 
further differences in the type of the 
predominant aggregation products. 
Oxidative modifications induced by 
EGCG have been described for other proteins 
(21), although apparently contrasting evidence is 
reported in the literature. Indeed, EGCG displays 
both anti-oxidant and pro-oxidant effects under 
different environmental conditions (21). In vitro 
assays have shown that EGCG is capable to 
scavenge different reactive species, such as the 
superoxide anion and hydroxyl radicals (35). On 
the other hand, the EGCG auto-oxidation can 
generate EGCG radical, superoxide radical, and 
hydrogen peroxide species (34, 36). It has been 
reported that one molecule of EGCG can 
produce about two molecules of hydrogen 
peroxide after overnight incubation in phosphate 
buffer pH 7, at a concentration of 0.022 mM ± 
0.22 mM (36). The different effects reported in 
the literature might be interpreted in terms of 
EGCG concentration relative to oxygen partial 
pressure (21). Although DA and EGCG have 
distinct AS-binding properties in terms of 
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affinity, conformational selectivity and 
conformational effects (20), protein modification 
by the two ligands takes place with only minor 
differences in the kinetics of the individual 
methionine residues, in line with a mechanism 
involving H2O2 production in the presence of 
either ligand. This is consistent with the fact that 
AS incubation with H2O2 results in the same 
covalent modifications as those reported here 
(data not shown) (37). 
oMet4 AS is endowed with a strongly 
reduced propensity to form amyloid fibrils 
relative to oMet0 (7). It has been suggested that 
this feature might derive from a reduced 
tendency to form E-type secondary structure. 
However, oMet0 and oMet4 AS display very 
similar structural properties, as assessed by 
various spectroscopic methods under several 
different conditions (7, 14, 16, 17). The same 
has been reported here for the highly helical 
conformation at high TFE concentrations, the E-
rich state in the presence of high MeOH 
concentrations, and the highly disordered state in 
aqueous buffers in the absence of ligands. 
Furthermore, the thermal stability of the intrinsic 
structural elements of the two protein variants is 
very similar. On the other hand, the here 
reported CD results show that differences 
emerge at intermediate points of the titrations 
with TFE and MeOH, in which the oxidized 
protein consistently displays a higher disorder 
content than unmodified AS. Such a trend is in 
agreement with FTIR data, showing restricted 
response to dehydration. The latter condition has 
been already shown to induce formation of 
intermolecular E-sheets (29).  
At the tertiary-structure level, oxidized 
AS displays slight amplification of ligand-
induced conformational changes, particularly 
with EGCG. This ligand stabilizes AS collapsed 
conformations, as shown by IM-MS, and this 
effect is more remarkable in the oxidized 
protein. This behavior could seem in contrast 
with the reduced chain flexibility caused by 
methionine oxidation (38). This result suggests 
that the change in side-chain chemical properties 
is the most relevant effect of oxidation and hints, 
in turn, to a predominant role of polar 
interactions mediating chain compaction in the 
presence of this polyphenolic ligand. 
The lower propensity of oMet4 AS to 
acquire ordered secondary structure, and 
particularly E-sheets, is relevant in the context of 
AS amyloid aggregation and could explain the 
inhibition of fibrillation potential by methionine 
oxidation. Indeed, fibrils, on-pathway oligomers 
and off-pathway oligomers are characterized by 
different type and content of secondary-structure 
elements (16, 39). Even minor differences in the 
relative stability of alternative conformers could 
strongly affect the evolution of ensembles 
governed by competing pathways. 
 
Experimental procedures 
Chemicals and proteins 
Ammonium acetate, ammonium 
hydroxide, DA, EGCG, acetonitrile, formic acid, 
acetic acid, chymotrypsin, ammonium 
bicarbonate, monosodium phosphate, disodium 
phosphate, TFE and MeOH were purchased 
from Sigma Aldrich (St. Louis, MO, USA). 
Wild-type human AS without any tag (average 
mass 14460.1 Da) was expressed in recombinant 
form and purified as previously described (40). 
  
AS oxidation analysis by ESI-MS 
Samples containing 70 ȝM AS were 
incubated at 37 °C in 50 mM ammonium acetate 
pH 7.0 under mild agitation (400 rpm) in the 
presence of 2 mM DA or 200 µM EGCG (20). 
Aliquots were taken every eight hours for three 
days, purified from salts and ligands by 
reversed-phase chromatography (Zip Tip C4 
Millipore, Burlington MA) and analyzed by ESI-
MS to determine AS oxidation levels. Part of the 
purified aliquots were frozen, dried and 
resuspended for in-solution digestion by 
chymotrypsin (Sigma Aldrich, St. Louis, MO). 
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Digestion were carried out at 1:50 
enzyme:substrate ratio (w/w), in 50 mM 
ammonium bicarbonate, and incubation at 37 °C 
for 18 h. The resulting peptides were desalted by 
Zip Tip C18 (Millipore, Burlington MA) and 
analyzed by ESI-MS and ESI-MS/MS, in order 
to map modifications and monitor oxidation 
kinetics.  
MS spectra of intact protein or 
chymotryptic peptides were collected in 
positive-ion mode, using a hybrid quadrupole-
time-of-flight mass spectrometer (QSTAR-Elite, 
AB Sciex, Foster City, CA) equipped with a 
nano-ESI source. Samples were infused at room 
temperature by metal-coated borosilicate 
capillaries (Thermo Fisher Scientific, Waltham, 
MA) with medium-length emitter tip of 1-µm 
internal diameter. The main instrumental 
parameters were set as follows: ion spray 
voltage 1.1-1.2 kV, declustering potential 100 V, 
curtain-gas pressure 20 psi.  Final spectra were 
obtained by averaging the signal over 2 min 
acquisition. All the data were processed by the 
software Analyst QS 2.0 (AB Sciex). Oxidation 
ratios for chymotryptic peptides were calculated 
as ratios between peptide peak high in MS 
spectra.  
Trypsin (Promega, Madison, WI) 
digestion was performed at 1:50 
enzyme:substrate ratio (w/w), in 100 mM 
ammonium bicarbonate, and incubation at 37 °C 
for  18 h. Trypsin-digested mixtures were 
analyzed by the Eksigent nanoLC-Ultra 2D 
System (Eksigent, AB SCIEX Dublin, CA, 
USA) RQ D QDQR /& FROXPQ  ȝP [  FP
3C18-CL,  ȝP  c WKURXJK D  PLQ
gradient of 5±60% of eluent B (eluent A, 0.1% 
formic acid in water; eluent B, 0.1% formic acid 
in acetonitrile), at a flow rate of 300 nL/min. 
Mass spectra were acquired using a LTQ-
OrbitrapXL-ETD mass spectrometer (Thermo 
Fisher Scientific, San José, CA, USA), equipped 
with a nanospray ionization source. Nanospray 
was achieved using a coated fused silica emitter 
(New Objective, WobuUQ 0$ 86$  ȝP
RGȝPLGȝPWLSLGKHOGDWN9
The ion transfer capillary was held at 220°C. 
Full mass spectra were recorded in positive ion 
mode over a 400±1600 m/z range and with a 
resolution setting of 30,000 FWHM and scan 
rate of 2 spectra per second, followed by five 
low-resolution MS/MS events, sequentially 
generated in a data-dependent manner on the top 
five most intense ions selected from the full MS 
spectrum, using dynamic exclusion for MS/MS 
analysis. All data generated were searched using 
the Sequest HT search engine contained in the 
Thermo Scientific Proteome Discoverer 
software, version 2.1. Methionine oxidation was 
set as dynamic modification. Oxidation extent 
was calculated as the ratio between PSMs of the 
oxidized and non-oxidized forms. This method 
counts the number of MS/MS spectra identified 
for a given peptide and, consequently, its 
relative abundance, in each analyzed condition. 
AS secondary structure by CD and FTIR 
oMet4 AS and oMet0 AS were buffer-
exchanged by Zeba Spin desalting columns 
(Thermo Fisher Scientific, Waltham, MA) with 
elution in 50 mM sodium phosphate pH 7.0. CD 
spectra in the far±UV range (190-260 nm) were 
acquired on a J-815 spectropolarimeter (JASCO 
Corporation, Tokyo, Japan), equipped with a 
Peltier system for temperature control. Samples 
were clarified by centrifugation at 10,000 g and 
measured in 50 mM sodium phosphate pH 7.0 in 
the presence of variable amounts of TFE or 
MeOH, employing a protein concentration of 10 
µM and quartz cuvette of 1-mm path length. The 
following instrumental settings were applied: 
data pitch 0.1 nm, scan speed 20 nm/min, 
bandwidth 1 nm, accumulation spectra 2. 
For FTIR analyses, the oMet0 and oMet4 
AS samples were measured in the form of a 
semi-dry film or in D2O solution. In particular, 2 
ȝ/ RI $6 VDPSOHV DW  PJP/ RI SURWHLQ
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concentration in 50 mM sodium phosphate pH 
7.0 were deposited on a BaF2 window and dried 
at room temperature, in order to obtain a solid 
film. The FTIR absorption spectra were then 
acquired in transmission mode by means of a 
Varian 670-IR FTIR spectrometer coupled to the 
Varian 610-IR infrared microscope (both from 
Varian, Mulgrave VIC, Australia Pty Ltd) (41), 
under the following instrumental settings: 2 cm-1 
spectral resolution, 25 kHz scan speed, 512 scan 
co-additions, triangular apodization, mercury 
cadmium telluride nitrogen-cooled detector, and 
a variable aperture of the microscope of 100 µm 
x 100 µm. Considering that the total amount of 
protein can still be different even within a fixed 
surface area, due to variability in film thickness, 
we compared only spectra of oMet0 and oMet4 
AS with similar Amide I areas. Since solvent 
evaporation can induce protein conformational 
changes and aggregation (29), it is particularly 
important to compare samples with similar 
protein contents. For conventional transmission-
mode measurements of the proteins in D2O 
solutions, (30, 31) lyophilized oMet0 and oMet4 
AS samples were resuspended in deuterated 50 
mM sodium phosphate pH 7.0 at a protein 
concentration of 5 mg/mL. A sample volume of 
 ȝ/ ZDV SODFHG LQ D WHPSHUDWXUH-controlled 
transmission cell with two BaF2 windows 
VHSDUDWHG E\ D  ȝP 7HIORQ VSDFHU DQG WKH
spectra were collected by using the Varian 670-
IR FTIR spectrometer as described above. To 
increase the signal-to-nose ratio, 1,000 scan co-
additions were employed. FTIR spectra were 
collected during the thermal treatment of the 
protein solutions from 25°C to 100°C at a 
heating rate of 0.4 °C/min. Protein absorption 
was obtained after subtraction of solvent 
absorption, measured under the same conditions. 
The FTIR spectra were baseline-corrected and 
the subtraction of residual vapor signals was also 
performed when necessary (31). All the 
absorption spectra were normalized for the 
Amide I band area. Second-derivative spectra 
were obtained after the smoothing of the 
measured spectra by the Savitzky Golay 
algorithm (42). Data collection and analysis 
were performed using the Resolutions-Pro 
software (Varian, Mulgrave VIC,Città, Australia 
Pty Ltd). 
 
SDS-PAGE 
Samples after the 72h-incubation were 
centrifuged for 10 minutes at 10,000 g to 
separate soluble and insoluble protein fractions. 
Pellets were resuspended into a volume identical 
to the supernatant (40 µL), and 6 µL of each 
fraction were run on 14% polyacrylamide gel 
electrophoresis on a mini-gel apparatus (Bio-
Rad, Hercules, CA, USA), according to the 
Laemmli protocol for SDS-PAGE (43) and 
stained by SimplyBlu  SafeStain (Life 
Technologies, Carlsbad, CA, USA). 
 
Ligand binding by native MS and IM-MS 
oMet4 AS was obtained by incubating 70 
µM oMet0 AS in 50 mM ammonium acetate pH 
7.0, 2 mM DA for 72 h at 37 °C under mild 
agitation. The resulting sample was buffer 
exchanged using 7k MWCO Zeba Spin desalting 
columns (Thermo Fisher Scientific, Waltham, 
MA) with elution in 50 mM ammonium acetate 
pH 7.0. oMet0 and oMet4 AS were mixed at final 
equimolar concentrations (20 µM) and analyzed 
by nano-ESI-(IM)-MS in the presence of  3 mM 
DA or 150 µM EGCG. 
Nano-ESI-(IM)-MS measurements were 
performed on a Synapt G2 HDMS (Waters, 
Manchester, U.K.) equipped with a nano-ESI 
sample source. Home-made gold-coated 
borosilicate capillaries were used to infuse the 
samples at room temperature. The main 
instrumental settings were: capillary voltage 1.5-
1.8 kV; sampling cone 25 V; extraction cone 1 
V; trap CE 4 V; transfer CE 0 V; trap bias 42 V. 
Gas pressures used throughout the instrument 
were: source 2.8 mbar; trap cell 2.4 x 10-2 mbar; 
IM cell 3.0 mbar; transfer cell 2.5 x 10-2 mbar. 
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Spectra were analyzed using Masslynx version 
4.1 and Driftscope version 2.3 (Waters, 
Manchester, U.K.). 
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FOOTNOTES 
The abbreviations used are: AS, Į-synuclein; CCS, collision cross-section; CD, circular dichroism; CSD, 
charge state distribution; DA, dopamine;  DHA, docosahexaenoic acid;  EGCG, epigallocatechin-3-
gallate;  ESI-MS, electrospray ionization mass spectrometry;  FTIR, Fourier transform infrared;  IDP, 
intrinsically disordered protein;  IM,  ion mobility;  MeOH, methanol;  MSR, methionine sulfoxide 
reductase;  oMet0 AS, fully UHGXFHGĮ-synuclein;  oMet4 AS, fully R[LGL]HGĮ-synuclein;  PD, Parkinson 
disease;  TFE, 2,2,2-trifluoroethanol. 
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Figure 1. Oxidation kinetics of intact AS. (A-C): ESI-MS peaks corresponding to the 15+ charge state of 
AS after 24-h incubation in the absence of ligands (A), in the presence of DA (B) and in the presence of 
EGCG (C). In each panel the peaks are labeled by the number of oxidized residues. (D, E): AS oxidation 
extent (0, black; 1, red; 2, blue; 3, green; 4, magenta, oxidized methionine residues) as a function of the 
incubation time in the presence of DA (D) or EGCG (E). Error bars indicate the standard deviation from 
three independent experiments. 
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Figure 2. Oxidation kinetics of AS methionine residues. (A-C): ESI-MS peaks corresponding to the 4+ 
charge state of the AS chymotryptic peptide containing Met116, after 24-h incubation in the absence of 
ligands (A), in the presence of DA (B) and in the presence of EGCG (C). (D-E): oxidation fraction of 
each methionine residue (M1, black; M5, red; M116, blue; M127, green) as a function of the incubation time 
in the presence of DA (D) or EGCG (E). Quantification for M116 and M127 has been performed on MS 
data on chymotryptic peptides. Quantification for M1 and M5 has been performed on MS/MS data on 
tryptic peptides. The black and red symbols are mostly overlaid for timepoint 40 h and beyond. Error bars 
indicate the standard deviation from at least three independent experiments. 
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Figure 3. Secondary structure transitions by CD spectroscopy. Far-UV CD spectra of oMet0 (black lines) 
and oMet4 (red lines) AS in the absence of organic solvents (A); in the presence of 10% (B) and 15% (C) 
TFE; in the presence of 35% (E) and 40% (f) MeOH. (D) SDS-PAGE analysis of supernatants (s) and 
pellets (p) obtained from the following samples: AS before incubation (ref); AS after 72h-incubation in 
the absence of ligands (AS); AS after 72h-incubation in the presence of DA (+DA); AS after 72h-
incubation in the presence of EGCG (+EGCG). The bands corresponding to AS monomer, fragments and 
oligomers are labeled. Representative data from at least three independent experiments are shown.
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Figure 4. Secondary structure transitions by FTIR spectroscopy. Absorption (A) and second-derivative 
(B) spectra of oMet0 (black lines) and oMet4 (red lines) AS measured in form of protein films obtained 
after solvent evaporation. (C) Absorption spectra of oMet0 and oMet4 AS measured in D2O solution at 
30°C. Second-derivative spectra of oMet0 (D) and oMet4 (E) AS measured in D2O solution at different 
temperatures from 25°C to 100°C. Arrows point to the spectral changes observed at increasing 
temperatures. The peak positions of the main components are shown. (F) Ratio of the intensity at 1655 
cm-1 and 1642 cm-1 taken from the second-derivative spectra of panels (D) and (E). Representative data 
from 3 (A, B) or 2 (C-F) independent experiments are shown. Error bars indicate the standard deviation.
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Figure 5. Ligand binding by native MS. (A, B) ESI-MS spectra of ternary mixtures of oMet0, oMet4 and 
either DA (A) or EGCG (B). The 11+ and 8+ peaks are labeled by the corresponding charge state. (C, D) 
Magnification of panels A and B in the region of the 11+ (C) and 8+ (D) charge state. The peaks of oMet0 
(black symbols) and oMet4 (red symbols) are labeled by the number of ligand molecules bound in the 
complex. Representative data from at least three independent experiments are shown. 
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Figure 6. Tertiary-structure transitions induced by ligand binding to AS by IM-MS. Collision cross 
section obtained from the 11+ (A) or 8+ (B) charge states of oMet0 and oMet4 complexes with ligands by 
IM-MS experiments, as a function of the number of bound ligand molecules (oMet0, black symbols; 
oMet4, red symbols). The relative intensities of the signals are expressed by a color scale (inset). 
Conformers are named by lower-case, italics letters. Representative data from at least three replicas are 
shown. 
SUPPORTING INFORMATION 
 
 
Methionine oxidation in -synuclein inhibits its propensity for ordered secondary structure 
 
Erika Ponzini1#, Antonella De Palma2#, Lucilla Cerboni1, Antonino Natalello1, Rossana Rossi2, Rani 
Moons3, Albert Konijnenberg3, Joanna Narkiewicz4, Giuseppe Legname4, Frank Sobott3,5, PierLuigi 
Mauri2, Carlo Santambrogio1* and Rita Grandori1* 
 
From the 1Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della 
Scienza 2, 20126 Milan, Italy; 2Institute of Biomedical Technologies, National Research Council of Italy, 
Segrate, Milan, Italy. 3Biomolecular & Analytical Mass Spectrometry, University of Antwerp, 
Groenenborgerlaan 171, 2020 Antwerp, Belgium; 4Department of Neuroscience, Scuola Internazionale 
6XSHULRUHGL6WXGL$YDQ]DWL6,66$DQG(/(775$í6LQFURWURQH7ULHVWH6&S$7ULHVWH,WDO\ ; 
5Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, LS2 9JT, U.K. 
 
 
 
 
Figure S1. NanoESI-MS/MS spectrum of AS chymotryptic peptide 126EMPSEEGYQDYEPEA140, 
fragmented by collision-induced dissociation (CID). Selected peaks are labeled by the fragment sequence. 
The diagnostic neutral loss of methanesulfenic acid from the side chain of the oxidized methionine residue is 
labeled in red. 
 
 
 Figure S2. ESI-MS peaks corresponding to the 2+ charge state of the AS chymotryptic peptide 
126EMPSEEGYQDYEPEA140, after 24-h incubation in the absence of ligands (A), in the presence of DA (B) 
or in the presence of EGCG (C). 
  
 Figure S3. AS tryptic peptide 1MDVFMK6 after 24h incubation in the presence of DA: (A) extract ion 
chromatogram of 770.36+1 m/z parent ion with no oxidation on Met1 and Met5, (B) its related MS spectrum 
zoom on isotopic distribution and (C) MS/MS fragmentation with residues confirmed by sequencing; (D) 
extract ion chromatogram of 802.35+1 m/z parent ion with Met1 and Met5 oxidized, (E) its related MS 
spectrum zoom on isotopic distribution and (F) MS/MS fragmentation with residues confirmed by 
sequencing. 
  
  
Figure S4. AS tryptic peptide 1MDVFMK6 after 24h incubation in the presence of EGCG: (A) extract ion 
chromatogram of 770.36+1 m/z parent ion with no oxidation on Met1 and Met5, (B) its related MS spectrum 
zoom on isotopic distribution and (C) MS/MS fragmentation with residues confirmed by sequencing; (D) 
extract ion chromatogram of 802.35+1 m/z parent ion with Met1 and Met5 oxidized, (E) its related MS 
spectrum zoom on isotopic distribution and (F) MS/MS fragmentation with residues confirmed by 
sequencing. 
  
 Figure S5. AS tryptic peptide 1MDVFMK6 after 24h incubation in the presence of DA. (A) MS spectrum 
zoom on 786.36+1 m/z parent ion corresponding to mono-oxidation on either Met1 or Met5. (B) and (C) 
MS/MS fragmentation of the two isobaric precursor ions, revealing the position of the modification. 
Protease Sequence Position Miscleavages Observed charges MH+ [Da] 
Trypsin 
AKEGVVAAAEK 11-20 1 1+,3+ 1072.608 
AKEGVVAAAEKTK 11-23 2 2+,3+ 1301.752 
DQLGK 98-102 0 1+ 560.303 
EGVLYVGSK 35-43 0 2+ 951.5391 
EGVVAAAEK 13-21 0 1+,2+ 873.491 
EGVVAAAEKTK 13-23 1 2+,3+ 1102.617 
EGVVHGVATVAEK 46-58 0 1+,2+,3+ 1295.733 
EGVVHGVATVAEKTK 46-60 1 2+,3+ 1524.842 
EGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQK 46-80 2 5+ 3433.894 
EGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVK 46-96 3 5+,6+ 4893.671 
EQVTNVGGAVVTGVTAVAQK 61-80 0 2+,3+ 1928.094 
EQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVK 61-96 1 3+ 3387.84 
EQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGK 61-102 3 5+ 4057.213 
GLSK 7-10 0 1+ 404.2501 
MDVFMK 1-6 0 1+,2+ 770.391 
MDVFMKGLSKAK 1-12 2 3+ 1354.757 
NEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA 103-140 0 4+ 4286.747 
QGVAEAAGK 24-32 0 1+,2+ 830.4589 
QGVAEAAGKTK 24-34 1 2+,3+ 1059.605 
QGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQK 24-80 6 7+,8+ 5636.118 
TKEGVLYVGSK 33-43 1 1+,2+ 1180.692 
TKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKK 33-97 7 8+ 6412.55 
TKEGVVHGVATVAEK 44-57 1 2+,3+,4+ 1524.84 
TKEGVVHGVATVAEKTK 44-60 2 3+,4+ 1753.994 
TKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQK 44-80 3 4+,5+ 3663.04 
TKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVK 44-96 4 6+,7+ 5122.841 
TKEQVTNVGGAVVTGVTAVAQK 59-80 1 2+,3+, 4+ 2157.243 
TKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKK 59-97 3 5+ 3745.085 
TKQGVAEAAGK 22-32 1 2+, 3+ 1059.586 
TVEGAGSIAAATGFVK 81-95 0 1+,2+,3+ 1478.763 
Chymotrypsin 
VKKDQLGKNEEGAPQEGILEDMPVDPDNEAY 95-125 3 3+, 4+ 3428.755 
SKAKEGVVAAAEKTKQGVAEAAGKTKEGVLY 9-39 1 5+, 6+ 3118.703 
VGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGF 40-94 1 5+, 6+, 7+ 5267.029 
EMPSEEGYQDYEPEA 126-140 2 2+ 1773.753 
MDVF 1-4 0 1+ 511.233 
GKNEEGAPQEGI 101-112 0 2+ 1228.728 
 
Table S1. List of peptide fragments identified after AS digestion. Peptides employed for oxidation 
quantification (together with the corresponding forms shifted by 16 or 32 Da) are shown in bold. 
MH+ [Da] (mass of the protonated, non-oxidized peptide expressed in Daltons). 
  
  
 
 
 
 
 
 
 
 
Table S2. Conformational profile of oxidized and non-oxidized AS in the presence of ligands, as assessed by 
nano-ESI-IM-MS. 
Column headers: oMet0 or oMet4 (non-oxidized or fully oxidized protein), followed by the number of DA or 
EGCG molecules bound.  
Av. average; S.D. standard deviation. 
Conformers a and b exist in the presence of DA (calculations based on 5 replicates). 
Conformers c. d. e. f. g exist in the presence of EGCG (calculations based on 4 replicates, except for oMet4-
2, which is based on 3 replicates). 
  
oMet0-0 oMet4-0  oMet0-1 oMet4-1 
 
 
 Av. (%) S.D. Av. (%) S.D. p-value Av. (%) S.D. Av. (%) S.D. p-value 
DA 
a 0.2 
±0.1 
0.3 
±0.1 
0.051 16.8 
±0.9 
19.9 
±0.8 
0.001 
b 99.8 99.7 0.051 83.2 80.0 0.001 
EGCG 
c 32.7 ±1.3 28.9 ±1.1 0.001 21.5 ±1.7 17.7 ±1.7 0.801 
d 32.8 ±0.8 29.4 ±0.9 0.256 24.7 ±1.6 22.1 ±2.3 0.855 
e 20.2 ±1.5 25.3 ±0.8 0.005 28.8 ±2.4 34.3 ±1.8 0.022 
f 11.9 ±1.6 13.3 ±0.6 0.004 16.9 ±0.3 16.8 ±1.8 0.169 
g 2.3 ±1.4 3.1 ±1.8 0.010 7.9 ±4.1 9.1 ±5.6 0.033 
